Immuno-imaging using nanobodies (Q37897404)

25 August 2017

1 reference

title

Immuno-imaging using nanobodies (English)

1 reference

25 August 2017

Catarina Xavier

1 reference

25 August 2017

Nick Devoogdt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21726996

6 December 2024

Ilse Vaneycken

1 reference

25 August 2017

Matthias D'huyvetter

1 reference

25 August 2017

Sophie Hernot

1 reference

25 August 2017

Jens De Vos

1 reference

25 August 2017

Vicky Caveliers

1 reference

25 August 2017

Tony Lahoutte

1 reference

25 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21726996

6 December 2024

publication date

2 July 2011

1 reference

full work available at URL

25 August 2017

https://api.elsevier.com/content/article/PII:S0958166911006215?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

https://api.elsevier.com/content/article/PII:S0958166911006215?httpAccept=text/plain

6 December 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Current Opinion in Biotechnology

6 December 2024

published in

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

877-881

1 reference

Molecular imaging: current status and emerging strategies

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Combined PET/MRI: one step further in multimodality imaging.

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciences

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Developing new molecular imaging probes for PET.

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Naturally occurring antibodies devoid of light chains

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Properties, production, and applications of camelid single-domain antibody fragments

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Camelid immunoglobulins and nanobody technology.

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Selection and identification of single domain antibody fragments from camel heavy-chain antibodies

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

A bispecific nanobody to provide full protection against lethal scorpion envenoming

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Immuno-PET: a navigator in monoclonal antibody development and applications.

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Antibodies and antimatter: the resurgence of immuno-PET.

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Antibody fragments: hope and hype

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Protein scaffold-based molecular probes for cancer molecular imaging

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Nanobodies as tools for in vivo imaging of specific immune cell types

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Efficient tumor targeting by single-domain antibody fragments of camels

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies.

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

Strategies to reduce renal radioactivity levels of antibody fragments

6 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.COPBIO.2011.06.009

6 December 2024

Identifiers

DOI

1 reference

release_3d4opp76knelfmcnro2myjygfm

25 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3d4opp76knelfmcnro2myjygfm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference